GMP BIO CO., LTD.

닫기

Treg CELL THERAPY

DEVELOPMENT

GMP BIO uses TTE01(Therapeutic Treg enhancer) system that can be used during many adaptations. This technology is a system that can separate, stimulate, and culture regulatory T cells, and is currently being developed as a dementia treatment for Alzheimer's disease.

Currently, the preclinical pharmacological efficacy assessment has been completed and the GLP preclinical toxicity assessment has been completed. Aimed at 2019 clinical trials
top